Supplementation of L-arginine prevents glucocorticoid-induced reduction of bone growth and bone turnover abnormalities in a growing rat model

Journal of Bone and Mineral Metabolism

Volumn 23, Issue 2, 2005, Pages 134-139

  Pennisi, Pietra ^a   D'Alcamo, Maria Antonia ^b   Leonetti, Concetta ^a   Clementi, Anna ^a   Cutuli, Vincenza Maria ^b   Riccobene, Stefania ^a   Parisi, Natalia ^a   Fiore, Carmelo Erio ^a  

^a Department of Internal Medicine OVE ^*  (Italy)

^b UNIVERSITY OF CATANIA   (Italy)

Author keywords

Bone growth; Glucocorticoids; L Arginine

Indexed keywords

ALKALINE PHOSPHATASE; ARGININE; CALCIUM; CARBOXY TERMINAL TELOPEPTIDE; COLLAGEN TYPE 1; GLUCOCORTICOID; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE DONOR; OSTEOCALCIN; PREDNISOLONE; SESAME SEED OIL;

ADOLESCENCE; ANIMAL EXPERIMENT; ARTICLE; BONE DENSITOMETRY; BONE DEVELOPMENT; BONE DISEASE; BONE GROWTH; BONE MINERAL; BONE TURNOVER; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG EFFECT; DRUG MECHANISM; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMUR; MALE; NONHUMAN; PELVIS; PRIORITY JOURNAL; RAT; RAT STRAIN; VERTEBRA;

ALKALINE PHOSPHATASE; ANIMALS; ARGININE; BODY WEIGHT; BONE DENSITY; BONE DEVELOPMENT; CALCIUM; COLLAGEN; COLLAGEN TYPE I; MALE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; OSTEOCALCIN; PEPTIDES; PREDNISOLONE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 17844365304     PISSN: 09148779     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00774-004-0551-x     Document Type: Article

References (24)

1. Lafage-Proust M, Boudignon B, Thomas T, (2003) Glucocorticoid-induced osteoporosis: pathophysiological data on recent treatments. Joint Bone Spine 70:109-118
2. Van Staa TP, Leufkens HG, Abenhaim L, Zhang B, Cooper C, (2000) Use of oral corticosteroids and risk of fractures. J Bone Miner Res 15:993-1000
3. Dempster DW, Arlot MA, Meunier PJ, (1983) Mean wall thickness and formation periods of trabecular bone packets in corticosteroid-induced osteoporosis. Calcif Tissue Int 35:410-417
4. Weinstein RS, Jilka RL, Parfitt AM, Manolagas SC, (1998) Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanism of their deleterious effects on bone. J Clin Invest 15:274-282
5. Hofbauer LC, Gori F, Riggs BL, Lacey DL, Dunstan CR, Spelsberg TC, Khosla S, (1999) Stimulation of osteoprotegerin ligand and inhibition of osteoprotegerin production by glucocorticoids in human osteoblastic lineage cells: potential paracrine mechanism of glucocorticoid-induced osteoporosis. Endocrinology 140:4382-4389
6. Dolan AL, Monitz C, Dasgupta B, Li F, Mackintosh C, Todd P, Corrigal V, Panayi GS, (1997) Effect of inflammation and treatment on bone turnover and bone mass in polymyalgia rheumatica. Arthritis Rheum 40:2022-2029
7. Pearce G, Tabensky DA, Delmas PD, Beker HW, Seeman E, (1998) Corticosteroid-induced bone loss in men. J Clin Endocrinol Metab 83:801-806
8. Ledro CD, Torres DY, Castro Laria L, Saenz Dana M, Herrerias, Esteban JM, (2000) Biochemical markers and bone densitometry in inflammatory bowel disease. Rev Esp Enferm Dig 92:595-600
9. Ardissone P, Rota E, Durelli L, Limone P, Isaia GC, (2002) Effects of high doses of corticosteroids on bone metabolism. J Endocrinol Invest 25:129-133
10. Koyama S, Kushida K, Takahashi M, Kawana K, Hoshimo H, Ishihara C, Inove T, (1998) Estimation of the effects of prednisolone on bone metabolism in rats by biochemical markers. J Bone Miner Metab 16:162-169
11. Ikeda S, Morishita Y, Tsutsumi H, Ito M, Shiraishi A, Arita S, Akahoshi S, Narusawa K, Nakamura T, (2003) Reductions in bone turnover, mineral, and structure associated with mechanical properties of lumbar vertebra and femur in glucocorticoid-treated growing minipigs. Bone 33:779-787
12. Wallerath T, Witte K, Schafer SC, Schwarz PM, Prellwitz W, Wohlfart P, Kleinert H, Lehr HA, Lemmer B, Forstermann U, (1999) Down-regulation of the expression of endothelial NO synthase is likely to contribute to glucocorticoid-mediated hypertension. Proc Natl Acad Sci USA 96:13357-13362
13. Van't Hoff RJ, Ralston SH, (2001) Nitric oxide and bone. Immunology 103:255-261
14. MacIntyre L, Zaidi M, Alam AS, Datta HK, Moonga BS, Lidbury PS, Hecker M, Vane JR, (1991) Osteoclast inhibition: an action of nitric oxide not mediated by cyclic GMP. Proc Natl Acad Sci USA 88:2936-2940
15. Wimalawansa SJ, De Marco G, Gangula P, Yallampalli C, (1996) Nitric oxide donor alleviates ovariectomy-induced bone loss. Bone 1996, 18:301-304
16. Wimalawansa SJ, Chapa MT, Yallampalli C, Zhang R, Simmons DJ, (1997) Prevention of corticosteroid-induced bone loss with nitric oxide donor nitroglycerin in male rats. Bone 21:275-280
17. Hulley PA, Conradie MM, Langeveldt CR, Hough FS, (2002) Glucocorticoid-induced osteoporosis in the rat is prevented by the tyrosine phosphatase inhibitor, sodium orthovanadate. Bone 31:220-229
18. Ralston SH, Ho LP, Helfrich MH, Grabowski PS, Iohnston PW, Benjamin N, (1995) Nitric oxide: a cytokine-induced regulator of bone resorption. J Bone Miner Res 10:1040-1049
19. Fiore CE, Pennisi P, Cutuli VM, Prato A, Messina R, Clementi G, (2000) L-Arginine prevents bone loss and bone collagen breakdown in cyclosporine A-treated rats. Eur J Pharmacol 408:323-326
20. Frost HM, Jee WSS, (1992) On the rat model of human osteopenias and osteoporoses. Bone Miner 18:227-236
21. Erben RG, (1996) Trabecular and endocortical bone surfaces in the rat: modeling or remodeling? Anat Rec 246:39-46
22. Iwamoto J, Shimamura C, Takeda T, Abe H, Ichimura S, Sato Y, Toyama Y, (2004) Effects of treadmill exercise on bone mass, bone metabolism, and calciotropic hormones in young growing rats. J Bone Miner Metab 22:26-31
23. Bianchi ML, (2002) Glucocorticoids and bone: some general remarks and some special observations in pediatric patients. Calcif Tissue Int 70:384-390
24. Wimalawansa S, Chapa T, Fang L, Yallampalli C, Simmons D, (2000) Frequency-dependent effect of nitric oxide donor nitroglycerin on bone. J Bone Miner Res 15:1119-1125